A Tumultuous Year for FDA: Perspectives and Predictions for 2026

When:
People:
Stuart M. Pape, Michael M. Gaba, Chad A. Landmon, Claire Davies
Register

This webinar was previously recorded. Click here to access the recording.

2025 brought dramatic and disruptive change to FDA and the industries it regulates. Join Polsinelli's experienced FDA team and special guest, Wayne Pines, for a roundtable discussion to reflect on the most notable developments of 2025 and explore whether 2026 will bring further change. How should stakeholders adjust to the new realities at FDA?

Agenda

  • How New Policies Have Impacted the Oversight of Drugs, Biologics and Vaccines
  • Food Policies in Transition: Synthetic Colors on the Way Out; GRAS is Next; Ultra Processed Foods Under Scrutiny
  • FDA’s 2026 Agenda and How Stakeholders Should Prepare
  • Litigation Developments and Potential Challenges in 2026